Board Certified Medical Affairs Specialist (BCMAS) Practice Exam

The main idea is that Phase III trials comparing two drugs are designed as randomized controlled trials. In this setup, participants are randomly assigned to receive either osamarin or losartan and are followed forward in time to assess predefined outcomes. Randomization helps ensure the groups are comparable on both known and unknown factors, so differences in outcomes can be attributed to the treatments themselves rather than other influences. The existence of a comparator group (the other drug) makes it a controlled trial. In contrast, a cohort study follows groups based on exposure without random assignment, a case-control study starts with an outcome and looks back for exposure, and a cross-sectional study assesses exposure and outcome at a single moment in time. Therefore, the described study is best classified as a randomized controlled trial.